Ann Arbor Hematoloty-Oncology — Ann Arbor, Michigan

Ann Arbor Hematoloty-Oncology is a clinical research site located in Ann Arbor, Michigan, United States 48106.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Ann Arbor Hematoloty-Oncology has participated in 1 clinical trials.

Therapeutic areas: Metastatic Renal Cell Carcinoma.

Sponsors: NewLink Genetics Corporation.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ann Arbor Hematoloty-Oncology?

Ann Arbor Hematoloty-Oncology has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ann Arbor Hematoloty-Oncology conducted?

Ann Arbor Hematoloty-Oncology has 1 clinical trials on record. Their work covers Metastatic Renal Cell Carcinoma.

Is Ann Arbor Hematoloty-Oncology accredited by Crixeo Health?

Ann Arbor Hematoloty-Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ann Arbor Hematoloty-Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.